April 7 (Reuters) - Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug ...
New recommendations suggest that some people should start trying to lower their cholesterol as early as age 30.
Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...
Between wearable tech like rings, smartwatches and tried-and-true blood pressure cuffs, it’s easier than ever to keep track ...
CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences ...
Federal regulators have approved the GLP-1 tablet Foundayo for weight loss. The once-daily oral pill provides an alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results